Toth D, Szeri F, Ashaber M, Muazu M, Szekvolgyi L, Aranyi T
Epigenetics Chromatin. 2025; 18(1):5.
PMID: 39819598
PMC: 11740433.
DOI: 10.1186/s13072-024-00566-2.
Borrego-Ruiz A, Borrego J
Genes (Basel). 2025; 15(12.
PMID: 39766866
PMC: 11675900.
DOI: 10.3390/genes15121599.
Bammidi L, Gayen S
Chromosoma. 2024; 133(4):217-231.
PMID: 39433641
DOI: 10.1007/s00412-024-00826-w.
Garge R, Lynch V, Fields R, Casadei S, Best S, Stone J
bioRxiv. 2024; .
PMID: 39282277
PMC: 11398484.
DOI: 10.1101/2024.09.05.609098.
Mizuno-Iijima S, Kawamoto S, Asano M, Mashimo T, Wakana S, Nakamura K
Mamm Genome. 2024; 35(4):497-523.
PMID: 39261329
PMC: 11522087.
DOI: 10.1007/s00335-024-10063-2.
Aortic disease and cardiomyopathy in patients with a novel DNMT3A gene variant causing Tatton-Brown-Rahman syndrome.
Zebrauskiene D, Sadauskiene E, Dapkunas J, Kairys V, Balciunas J, Konovalovas A
Clin Epigenetics. 2024; 16(1):76.
PMID: 38845031
PMC: 11157947.
DOI: 10.1186/s13148-024-01686-y.
CDCA7-associated global aberrant DNA hypomethylation translates to localized, tissue-specific transcriptional responses.
Vukic M, Chouaref J, Della Chiara V, Dogan S, Ratner F, Hogenboom J
Sci Adv. 2024; 10(6):eadk3384.
PMID: 38335290
PMC: 10857554.
DOI: 10.1126/sciadv.adk3384.
Rapid and accurate remethylation of DNA in deficient hematopoietic cells with restoration of DNMT3A activity.
Li Y, Abel H, Cai M, LaValle T, Yin T, Helton N
Sci Adv. 2024; 10(5):eadk8598.
PMID: 38295174
PMC: 10830114.
DOI: 10.1126/sciadv.adk8598.
Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia.
Humphries S, Bond D, Germon Z, Keely S, Enjeti A, Dun M
Clin Epigenetics. 2023; 15(1):150.
PMID: 37705055
PMC: 10500762.
DOI: 10.1186/s13148-023-01566-x.
H3K36 methylation maintains cell identity by regulating opposing lineage programmes.
Hoetker M, Yagi M, Di Stefano B, Langerman J, Cristea S, Wong L
Nat Cell Biol. 2023; 25(8):1121-1134.
PMID: 37460697
PMC: 10896483.
DOI: 10.1038/s41556-023-01191-z.
Dnmt3bas coordinates transcriptional induction and alternative exon inclusion to promote catalytically active Dnmt3b expression.
Dar M, Mensah I, He M, McGovern S, Sohal I, Whitlock H
Cell Rep. 2023; 42(6):112587.
PMID: 37294637
PMC: 10592478.
DOI: 10.1016/j.celrep.2023.112587.
Biomarkers of aging.
Bao H, Cao J, Chen M, Chen M, Chen W, Chen X
Sci China Life Sci. 2023; 66(5):893-1066.
PMID: 37076725
PMC: 10115486.
DOI: 10.1007/s11427-023-2305-0.
DNA Methylation: Genomewide Distribution, Regulatory Mechanism and Therapy Target.
Kaplun D, Kaluzhny D, Prokhortchouk E, Zhenilo S
Acta Naturae. 2023; 14(4):4-19.
PMID: 36694897
PMC: 9844086.
DOI: 10.32607/actanaturae.11822.
DNMT3B supports meso-endoderm differentiation from mouse embryonic stem cells.
Lauria A, Meng G, Proserpio V, Rapelli S, Maldotti M, Polignano I
Nat Commun. 2023; 14(1):367.
PMID: 36690616
PMC: 9871038.
DOI: 10.1038/s41467-023-35938-x.
DNMT3B overexpression downregulates genes with CpG islands, common motifs, and transcription factor binding sites that interact with DNMT3B.
Loaeza-Loaeza J, Cerecedo-Castillo A, Rodriguez-Ruiz H, Castro-Coronel Y, Del Moral-Hernandez O, Recillas-Targa F
Sci Rep. 2022; 12(1):20839.
PMID: 36460706
PMC: 9718745.
DOI: 10.1038/s41598-022-24186-6.
Epigenetic regulation of aging: implications for interventions of aging and diseases.
Wang K, Liu H, Hu Q, Wang L, Liu J, Zheng Z
Signal Transduct Target Ther. 2022; 7(1):374.
PMID: 36336680
PMC: 9637765.
DOI: 10.1038/s41392-022-01211-8.
Identification of DNA methylation-regulated genes as potential biomarkers for coronary heart disease via machine learning in the Framingham Heart Study.
Zhang X, Wang C, He D, Cheng Y, Yu L, Qi D
Clin Epigenetics. 2022; 14(1):122.
PMID: 36180886
PMC: 9526342.
DOI: 10.1186/s13148-022-01343-2.
Repression and 3D-restructuring resolves regulatory conflicts in evolutionarily rearranged genomes.
Ringel A, Szabo Q, Chiariello A, Chudzik K, Schopflin R, Rothe P
Cell. 2022; 185(20):3689-3704.e21.
PMID: 36179666
PMC: 9567273.
DOI: 10.1016/j.cell.2022.09.006.
Genomic targets and selective inhibition of DNA methyltransferase isoforms.
Sae-Lee C, Barrow T, Colicino E, Choi S, Rabanal-Ruiz Y, Green D
Clin Epigenetics. 2022; 14(1):103.
PMID: 35987848
PMC: 9392947.
DOI: 10.1186/s13148-022-01325-4.
Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells.
Maietta I, Martinez-Perez A, Alvarez R, de Lera A, Gonzalez-Fernandez A, Simon-Vazquez R
Pharmaceuticals (Basel). 2022; 15(7).
PMID: 35890123
PMC: 9323654.
DOI: 10.3390/ph15070824.